# Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor‐ to dolutegravir‐based antiretroviral therapy: A prospective cohort study in Lesotho (DO‐REAL study)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/viral-suppression-after-transition-from-nonnucleoside-reverse-transcriptase/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jennifer Anne Brown,Bienvenu Lengo Nsakala,Kuena Mokhele,Itumeleng Rakuoane,Josephine Muhairwe,Lorena Urda,Alain Amstutz,Nadine Tschumi,Thomas Klimkait,Niklaus Daniel Labhardt |
| Citations | 40 |
| DOI | 10.1111/hiv.13189 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1111/hiv.13189 |
| OpenAlex ID | https://openalex.org/W3207929571 |
| PMID | 34632682 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Jennifer Anne Brown](https://scholariq.org/researchers/jennifer-anne-brown/)

## Paper primary topic

- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)

## Paper topics

- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [HIV/AIDS Research and Interventions](https://scholariq.org/topics/hiv-aids-research-and-interventions/)
- [HIV-related health complications and treatments](https://scholariq.org/topics/hiv-related-health-complications-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.